PVI
Pura Vida Investments Portfolio holdings
AUM
$16.6M
This Quarter Return
+3.9%
1 Year Return
-3.82%
3 Year Return
-0.02%
5 Year Return
+29.84%
10 Year Return
+256.58%
AUM
$328M
AUM Growth
+$328M
(+15%)
Cap. Flow
+$30.9M
Cap. Flow
% of AUM
9.43%
Top 10 Holdings %
Top 10 Hldgs %
45.79%
Holding
116
New
20
Increased
20
Reduced
14
Closed
21
Top Buys
| 1 |
Smith & Nephew
SNN
|
$10.9M |
| 2 |
STAAR Surgical
STAA
|
$7.16M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
$6.26M |
| 4 |
Zimmer Biomet
ZBH
|
$5.89M |
| 5 |
Bruker
BRKR
|
$5M |
Top Sells
| 1 |
Dentsply Sirona
XRAY
|
$10.4M |
| 2 |
Axogen
AXGN
|
$6.79M |
| 3 |
Axsome Therapeutics
AXSM
|
$5.3M |
| 4 |
CELG
Celgene Corp
CELG
|
$4.72M |
| 5 |
Globus Medical
GMED
|
$3.95M |
Sector Composition
| 1 | Healthcare | 89.84% |
| 2 | Industrials | 2.49% |
| 3 | Consumer Staples | 1.36% |
| 4 | Materials | 0.27% |
| 5 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Inspire Medical Systems
INSP
$2.77B
| $24.3M | 3.68% | 400,000 +41,500 | +12% | +$2.52M |
|
|
NSTG
2
DELISTED
NanoString Technologies, Inc.
NSTG
| $21.9M | 3.32% | 720,915 +69,474 | +11% | +$2.11M |
|
3
ICU Medical
ICUI
$3.15B
| $19.9M | 3.03% | 79,119 +5,500 | +7% | +$1.39M |
|
|
4
Zimmer Biomet
ZBH
$21B
| $18.8M | 2.86% | 160,000 +50,000 | +45% | +$5.89M |
|
|
5
STAAR Surgical
STAA
$1.36B
| $15.8M | 2.4% | 538,600 +243,758 | +83% | +$7.16M |
|
|
6
Smith & Nephew
SNN
$16.3B
| $10.9M | 1.65% | +250,000 | New | +$10.9M |
|
7
Establishment Labs
ESTA
$1.2B
| $10.8M | 1.63% | 489,490 +167,765 | +52% | +$3.69M |
|
8
Boston Scientific
BSX
$156B
| $10.1M | 1.53% | 235,000 +25,000 | +12% | +$1.07M |
|
9
DexCom
DXCM
$29.5B
| $9.33M | 1.42% | 62,287 -2,500 | -4% | -$375K |
|
|
RCM
10
DELISTED
R1 RCM Inc. Common Stock
RCM
| $8.14M | 1.24% | 647,141 +190,000 | +42% | +$2.39M |
|
|
AGN
11
DELISTED
Allergan plc
AGN
| $7.89M | 1.2% | 47,109 +4,984 | +12% | +$834K |
|
|
VRAY
12
DELISTED
ViewRay, Inc.
VRAY
| $7.49M | 1.14% | 850,000 -346,805 | -29% | -$3.06M |
|
13
Danaher
DHR
$147B
| $7.15M | 1.09% | 50,000 +5,000 | +11% | +$715K |
|
|
XENT
14
DELISTED
Intersect ENT, Inc
XENT
| $7.07M | 1.07% | 310,826 +115,000 | +59% | +$2.62M |
|
|
ARQL
15
DELISTED
Arqule Inc
ARQL
| $6.98M | 1.06% | 633,789 +250,289 | +65% | +$2.76M |
|
16
Gilead Sciences
GILD
$140B
| $6.76M | 1.03% | 100,000 | – | – |
|
|
17
Regeneron Pharmaceuticals
REGN
$61.5B
| $6.26M | 0.95% | +20,000 | New | +$6.26M |
|
18
Guardant Health
GH
$8.41B
| $6.04M | 0.92% | 70,000 -43,800 | -38% | -$3.78M |
|
19
AbbVie
ABBV
$372B
| $5.82M | 0.88% | 79,980 +35,000 | +78% | +$2.55M |
|
20
OrthoPediatrics
KIDS
$536M
| $5.63M | 0.86% | 144,408 +24,408 | +20% | +$952K |
|
21
Masimo
MASI
$7.59B
| $5.58M | 0.85% | 37,500 +5,000 | +15% | +$744K |
|
|
22
Bruker
BRKR
$5.16B
| $5M | 0.76% | +100,000 | New | +$5M |
|
23
Orthofix Medical
OFIX
$592M
| $4.96M | 0.75% | 93,794 -11,206 | -11% | -$593K |
|
|
IVC
24
DELISTED
Invacare Corporation
IVC
| $4.83M | 0.73% | 929,576 +143,137 | +18% | +$743K |
|
25
Avantor
AVTR
$9.18B
| $4.77M | 0.72% | +250,000 | New | +$4.77M |
|